Nothing about the increase in the number of patients getting Daybue? Nothing about the dropout rate or how families are coping with the side effects? Is there any progress in managing the side effects to improve the retention rate? The link in NEU's announcement doesn't even take us directly to the conference call - it only takes us to Acadia's website and then we have to navigate through there to find the conference call. I cannot find the conference call on their website. And there's nothing in Acadia's announcement on their progress on getting Daybue registered anywhere else in the world. No wonder the market is a bit annoyed and the share price has dropped so much. Couldn't NEU have added a bit more detail to their part of the announcement?
Ann: DAYBUE net sales US$87.1 million in Q4 2023, page-38
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.99 |
Change
0.020(0.10%) |
Mkt cap ! $2.555B | |||
| Open | High | Low | Value | Volume |
| $19.91 | $20.19 | $19.77 | $5.636M | 281.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 193 | $19.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 722 | 2 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |